TickerFactsScreenerDevelopers

Esperion Therapeutics, Inc. (ESPR) — Total Liabilities

Annual figures by fiscal year, from SEC filings.

2012: $24.70M2013: $4.20M2014: $9.72M2015: $8.31M2016: $16.61M2017: $33.14M2018: $64.33M2019: $194.50M2020: $449.39M2021: $578.53M2022: $571.72M2023: $660.79M2024: $732.54M2025: $767.85M$767.85M
2012Total Liabilities (USD)2025
Fiscal YearTotal LiabilitiesChange YoY
2025$767.85M+4.8%
2024$732.54M+10.9%
2023$660.79M+15.6%
2022$571.72M-1.2%
2021$578.53M+28.7%
2020$449.39M+131.1%
2019$194.50M+202.3%
2018$64.33M+94.1%
2017$33.14M+99.5%
2016$16.61M+99.8%
2015$8.31M-14.5%
2014$9.72M+131.3%
2013$4.20M-83.0%
2012$24.70M—